Company highlights its global expertise and new and expanded capabilities to help biopharma and biotech customers solve global health challenges Thermo ...
This approval is supported by data from the Phase III OASIS clinical trial program evaluating Lynkuet for the treatment of moderate to severe hot fla...
Cytiva, a global leader in life sciences and bioprocessing technologies under the Danaher Corporation umbrella, has announced the appointment of Val&eacu...
SK pharmteco, a global contract development and manufacturing organization (CDMO), announced today a $6.1 million investment in its Rancho Cordova facili...
Labs will soon have access to filtration products made with ISCC PLUS-certified biobased resins Certified materials enable labs to choose more sustainab...
Acquisition focused on lead clinical-stage program ICT01 in acute myeloid leukemia, where data from the ongoing Phase I/II EVICTION trial showed high t...
Move follows ProImmune’s recent acquisition of Oasis Park a 70,000 sq ft Business and Light Industrial Park in Oxford, UK Increased operationa...
Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, and Profluent Bio, a leader in AI-first protein design, have activate...
Minerva secures $80 million up front and up to an additional $80 million subject to the full exercise of Tranche A warrants. Minerva and the FDA have ...
Dedicated facilities for gelatin and HPMC; 200+ jobs; operations targeted for early 2027; expands ACG's 25-year U.S. presence ACG, the world's most inte...
Adcytherix Raises EUR 105M Series A to Accelerate Breakthrough Antibody-Drug Conjugate Pipeline with Strategic Focus on Novel Payloads Financing led b...
Agios Pharmaceuticals, Inc. (Nasdaq: AGIO), a commercial-stage biopharmaceutical company focused on delivering innovative medicines for patients with rar...
Resilience is no longer a corporate slogan — it’s the new currency of survival in biopharma. As the sector races between scientific breakthroug...
-Kezar Life Sciences, Inc. a clinical-stage biotechnology company developing novel small molecule therapeutics to treat unmet needs in immune-mediated di...
© 2025 Biopharma Boardroom. All Rights Reserved.
